Trial intelligence / Profile preview

Milnacipran in Chronic Back Pain

NCT01221740Phase 3Withdrawn

Sponsor
Brigham and Women's Hospital
Start
Aug 2010
Primary completion
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of milnacipran in back pain, sponsored by Brigham and Women's Hospital. Planned start Aug 2010; status: withdrawn.

02

Drugs

milnacipran
03

Conditions

back pain

Beyond the preview

Go deeper on NCT01221740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01221740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call